Net Loss of Kabra Drugs reported to Rs 0.11 crore in the quarter ended December 2023 as against net loss of Rs 0.06 crore during the previous quarter ended December 2022. There were no Sales reported in the quarter ended December 2023 and during the previous quarter ended December 2022.Powered by Capital Market - Live News

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 14 February 2024.Powered by Capital Market - Live News

Kabra Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 17 February 2024 .Powered by Capital Market - Live News

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 23 January 2024.Powered by Capital Market - Live News

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 15 December 2023.Powered by Capital Market - Live News